María A. Barceló

#Kidney disease and glomerular filtration

Duration and dosing of proton pump inhibitors associated with high incidence of chronic kidney disease in population-based cohort

Rodríguez-Poncelas A, Barceló MA, Saez M, Coll-de-Tuero G. PlosOne 2018; 13(10):e0204231. doi: 10.1371/journal.pone.0204231 (Impact Factor: 2.776, MULTIDISCIPLINARY SCIENCES, 15/64 Q1)

Download

Andersen-Gill model Clinical epidemiology FRCV Kidney disease and glomerular filtration Method:Survival analysis Q1 Selection on unobservables:Mixed models Selection on unobservables:Space-time models

Prediabetes is associated with glomerular hyperfiltration in a european mediterranean cohort study

Rodríguez-Poncelas A, Coll-de-Tuero G, Blanch J, Comas-Cufí M, Saez M, Barceló MA. Journal of Nephrology 2018; 31(5):743-749. doi: 10.1007/s40620-018-0524-0 (Impact Factor: 3.698, UROLOGY & NEPHROLOGY, 13/80 Q1)

Clinical epidemiology Cox model FRCV Kidney disease and glomerular filtration Method:Survival analysis Q1 Selection on observables:Matching

Prognostic value of the estimated glomerular filtration rate decline in hypertensive patients without chronic kidney disease

Coll-de-Tuero G, Comas-Cufí M, Rodríguez-Poncelas A, Barrot J, Blanch J, Figa A, Barceló MA , Saez M. American Journal of Hypertension 2019; 32(9):890-899. doi: 10.1093/ajh/hpz029 (Impact Factor: 2.530, PERIPHERAL VASCULAR DISEASE 33/65 Q3)

Clinical epidemiology FRCV GLM model Kidney disease and glomerular filtration Method:Generalized models Q3 Selection on observables:Regression models